| Igama | Daptomycin |
| Inombolo yeCAS | 103060-53-3 |
| Ifomula yemolekyuli | I-C72H101N17O26 |
| Ubunzima bemolekyuli | 1620.67 |
| Inombolo ye-EINECS | 600-389-2 |
| Indawo yokunyibilika | 202-204°C |
| Indawo yokubilisa | 2078.2±65.0 °C (Kuxelwe kwangaphambili) |
| Ukuxinana | 1.45±0.1 g/cm3(Kuxelwe kwangaphambili) |
| Indawo yokuflasha | 87℃ |
| Iimeko zokugcina | Itywinwe kwindawo eyomileyo, Gcina kwisikhenkcisi, ngaphantsi kwe -20°C |
| Ukunyibilika | I-Methanol:i-soluble5mg/mL |
| I-acidity coefficient | (pKa) 4.00±0.10 (Kuxelwe kwangaphambili) |
| Ifom | umgubo |
| Umbala | engenambala ukuya kumthubi |
N-[N-(1-Oxodecyl)-L-Trp-D-Asn-L-Asp-]-cyclo[L-Thr*-Gly-L-Orn-L-Asp-D-Ala-L-Asp-Gly-D-Ser-[(3R)-3-methyl-L-Glu-]-4-(2-L-4-abuny) ;N-[N-Decanoyl-L-Trp-D-Asn-L-Asp-]-cyclo[Thr*-Gly-L-Orn-L-Asp-D-Ala-L-Asp-Gly-D-Ser-[(3R)-3-methyl-L-Glu-]-3-(2-aminobenzo-la-Od-Oxoyl)-; ecyl)-L-tryptophyl-D-asparaginyl-L-α-aspartyl-L-threonylglycyl-L-ornithinyl-L-α-aspartyl-D-alanyl-L-α-aspartylglycyl-D-seryl-(3R)-3-methyl-L-α- glutamyl-α,2-diamino-γ-oxo-benzenebutanoicacid(13-4)lactone;DAPTOMYCINE;Dapcin;Daptomycin,>=99%;DaptomycinReadyMadeSolution;Daptomycin(LY146032)
I-antibiotic daptomycin yi-antibiotic ye-cyclic lipopeptide enesakhiwo esitsha esithathwe kumhluzi wokuvundiswa kweStreptomyces (S. reseosporus), ethintela i-biosynthesis ye-bacterial cell wall peptidoglycan ngokuphazamisa ukuthuthwa kwe-amino acids kwi-membrane yeseli. Ukutshintsha iimpawu ze-membrane ye-cytoplasmic kunokuphazamisa umsebenzi we-membrane yebhaktheriya ngeendlela ezininzi kwaye ubulale ngokukhawuleza ibhaktheriya ye-Gram-positive. Ukongeza kwisakhono sayo sokusebenza kwiibhaktheriya zeGram-positive, i-daptomycin ibaluleke ngakumbi kwiintlobo ezizimeleyo ezibonise ukuxhathisa i-methicillin, i-vancomycin, kunye ne-linezolid in vitro. Inomsebenzi onamandla, kwaye le propati ineempembelelo zeklinikhi ezibaluleke kakhulu kwizigulana ezigula kakhulu. I-Eosinophilic pneumonia sisifo esinqabileyo kwaye esibi kakhulu sineempawu ezibandakanya umkhuhlane, ukukhohlela, ukuphefumla nzima, kunye nobunzima bokuphefumla.
I-Daptomycin inomsebenzi olungileyo we-bacteriostatic ngokuchasene neebhaktheriya ezahlukeneyo ezichasene ne-antibiotic, njenge-MIC=0.06-0.5 μg/ml ye-methicillin-resistant Staphylococcus aureus (MRSA), kunye ne-methicillin-resistant Staphylococcus aureus (MRSA). I-MIC=0.0625~1μg/ml yebhaktheriya, i-MIC=0.12~0.5μg/ml ye-oxacillin-resistant Staphylococcus epidermidis, MIC=2.5μg/ml ye-enterococcus exhathisa kakhulu kwi-aminoglycoside antibiotics, i-MICmrBI ye-GICm2 ye-GIC = ye-Gm2. I-Enterococcus yi-0.5~1μg/ml, kwaye i-MIC ye-Enterococcus echasene ne-glycopeptide antibiotics yi-1~2μg/ml.